Jobs Jetty helps you send them a short, personal note from your own resume.
Raised Series A ($122M), Jul 2024
NGM Biopharmaceuticals develops medicines based on human biology. Its lead candidate NGM120 is in Phase 2 trials for hyperemesis gravidarum and cancer cachexia.
Research · 76 people · South San Francisco, United States
Join to see who to write to, then send them a note in your own words.
Join Jobs Jetty